Moneycontrol PRO
Live: Commodity Markets Live: Coffee Prices Are Steaming Up; Here's Why

Inequity in distribution: Gujarat gets highest supply of COVID-19 vaccines vis-a-vis population; Maharashtra ranks 14th

Though Maharashtra tops in getting absolute number of vaccines, when taken in proportion to its population, it lags behind states such as Gujarat, Kerala, Chhattisgarh, Haryana and Karnataka.

April 19, 2021 / 01:51 PM IST
A patient lies in a bed as she is being shifted to a hospital for treatment, amidst the spread of the coronavirus disease (COVID-19) in Ahmedabad, India, April 15, 2021. REUTERS/Amit Dave - RC27WM9GHP3Y

A patient lies in a bed as she is being shifted to a hospital for treatment, amidst the spread of the coronavirus disease (COVID-19) in Ahmedabad, India, April 15, 2021. REUTERS/Amit Dave - RC27WM9GHP3Y

Is there a problem in the way the quantum of vaccine supply is decided for each state in India? In fact, how is it done?

These questions are increasingly being aired even as the second wave of COVID-19 goes on a rampage across the country. Several states continue to complain about vaccine shortage.

Hospitals in many states, including those in Delhi, Maharashtra, Karnataka and Chhattisgarh, have either run out of doses, or just have a few days of supply left.

The Government of India contends that the issue is not about supply, but of planning. "We are giving four days’ supply to the big states and replenishing it every four to five days. Small states get seven to eight days’ vaccine supply, which is replenished after that period. State governments need to see the status of doses on a daily basis, just like the exercise we do in the health ministry every day,” Health Secretary Rajesh Bhushan explained the methodology on April 14.

But one thing is still not clear. How is a day's supply calculated for each state? Is it same, or different, for each state?


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Also, not all states agree with what Bhushan said. For instance, a Print report on April 14 quotes Chhattisgarh health minister TS Singh Deo alleging that the state hadn't got supplies "in last one week," despite being promised of fresh doses 'within two-three days.'

Chief ministers of Delhi and Maharashtra, the two most impacted states, have been vocal on their demands for more supply. This is despite Maharashtra continuing to get the highest number of doses.

No correlation with population?

One possible explanation of the mis-match between demand and supply, would be that the doses allocated to each state may not be in accordance with their population.

To understand better, Moneycontrol looked at the data of total doses supplied to 24 states and union territories in India, and compared this to their population. We also looked at the percentage of population that have received at least the first dose. Data for the rest of the states and union territories were unavailable.

We took the data from several sources. The data on vaccine administration was taken from the website of the Ministry of Health and Family Welfare. The ministry didn't have data on vaccine supplies to each state. A Health Ministry spokesperson said it did not have the data. We thus took data from media reports, including this report, which was partly corroborated by Minister Harsh Vardhan in this tweet. 

What the data said

Though Maharashtra has been reporting the highest number of cases, and has been getting the biggest share in vaccine supplies, the picture changes when one takes into account its population.

As on April 8, the supplies to Maharashtra covered just about 8.5 percent of the population. For Delhi, it was 10.4 percent.

On the other hand, Gujarat, which can't be regarded as the most impacted state if one goes by official numbers, had got enough vaccines for 16.4 percent of its population - the highest. Kerala comes second with 16.1 percent and Chhattisgarh third with 15.8 percent.

Uttar Pradesh and Bihar, among the most populous states in the country, make up for the bottom of the table.

vaccine graphic

"The data surely shows there is a lack of logic or consistency in allocating doses. Maharashtra had a right to be upset," said an observer tracking the COVID-19 cases in India.

Another official said that the allocation may not be even in accordance to the incidence of COVID-19 infection.

And it's not that these states didn't have the capability, or the infrastructure, to administer more. Maharashtra, Odisha and West Bengal, for instance, have done a good job in administering the vaccines that was supplied them (See graph). Some others, including Gujarat, Chhattisgarh and Goa haven't been that successful.

The hope now is that the supply will get a boost with India approving the Sputnik V vaccine. Drugmaker Dr Reddy's had said it will be importing Sputnik V vaccine from Russia in this quarter, and supplies from Indian manufacturers will commence from next quarter. Also, the government has fast-tracked emergency approval for foreign-made jabs.

By then, observers hope, the supplies of vaccine will be commensurate with a state's population, and incidence of infection.

With inputs from Arup Roychoudhury.
Prince Mathews Thomas heads the corporate bureau of Moneycontrol. He has been covering the business world for 16 years, having worked in The Hindu Business Line, Forbes India, Dow Jones Newswires, The Economic Times, Business Standard and The Week. A Chevening scholar, Prince has also authored The Consolidators, a book on second generation entrepreneurs.
first published: Apr 16, 2021 03:38 pm
ISO 27001 - BSI Assurance Mark